Clearer insights into IgE glycosylation will enhance understanding and treatment of allergy and IgE-mediated atopic diseases and will help inform the development of novel antibody scaffolds aimed at filling the gaps in existing monoclonal antibodies for cancer therapy. Here, IGHE is linked to allergic disease.